287 related articles for article (PubMed ID: 28656266)
1. Peroxisome proliferator-activated receptor γ agonist suppresses mast cell maturation and induces apoptosis.
Zhang Y; Li X; Fang S; Zhu Z; Yao M; Ying L; Zhu L; Ma Z; Wang W
Mol Med Rep; 2017 Aug; 16(2):1793-1800. PubMed ID: 28656266
[TBL] [Abstract][Full Text] [Related]
2. Pioglitazone induces cell growth arrest and activates mitochondrial apoptosis in human uterine leiomyosarcoma cells by a peroxisome proliferator-activated receptor γ-independent mechanism.
Lützen U; Zhao Y; Lucht K; Zuhayra M; Marx M; Cascorbi I; Culman J
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):37-48. PubMed ID: 27664035
[TBL] [Abstract][Full Text] [Related]
3. Stem cell factor and interleukin-4 induce murine bone marrow cells to develop into mast cells with connective tissue type characteristics in vitro.
Karimi K; Redegeld FA; Heijdra B; Nijkamp FP
Exp Hematol; 1999 Apr; 27(4):654-62. PubMed ID: 10210323
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of peroxisome proliferator-activated receptor γ agonists on collagen IV production in podocytes.
Li Y; Shen Y; Li M; Su D; Xu W; Liang X; Li R
Mol Cell Biochem; 2015 Jul; 405(1-2):233-41. PubMed ID: 25920446
[TBL] [Abstract][Full Text] [Related]
5. Functional expression of high-affinity receptor for immunoglobulin E on mast cells precedes that of tryptase during differentiation from human bone marrow-derived CD34 progenitors cultured in the presence of stem cell factor and interleukin-6.
Shimizu Y; Suga T; Maeno T; Aoki F; Tsukagoshi H; Kawata T; Sakai K; Narita T; Takahashi T; Ishikawa S; Morishita Y; Nakajima T; Hara F; Miura T; Kurabayashi M
Clin Exp Allergy; 2004 Jun; 34(6):917-25. PubMed ID: 15196280
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor-gamma agonists promote differentiation and antioxidant defenses of oligodendrocyte progenitor cells.
Bernardo A; Bianchi D; Magnaghi V; Minghetti L
J Neuropathol Exp Neurol; 2009 Jul; 68(7):797-808. PubMed ID: 19535992
[TBL] [Abstract][Full Text] [Related]
7. Characterization of 'adult-type' mast cells derived from human bone marrow CD34(+) cells cultured in the presence of stem cell factor and interleukin-6. Interleukin-4 is not required for constitutive expression of CD54, Fc epsilon RI alpha and chymase, and CD13 expression is reduced during differentiation.
Shimizu Y; Sakai K; Miura T; Narita T; Tsukagoshi H; Satoh Y; Ishikawa S; Morishita Y; Takai S; Miyazaki M; Mori M; Saito H; Xia H; Schwartz LB
Clin Exp Allergy; 2002 Jun; 32(6):872-80. PubMed ID: 12047434
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor-gamma ligand reduced tumor necrosis factor-alpha-induced interleukin-8 production and growth in endometriotic stromal cells.
Ohama Y; Harada T; Iwabe T; Taniguchi F; Takenaka Y; Terakawa N
Fertil Steril; 2008 Feb; 89(2):311-7. PubMed ID: 17555752
[TBL] [Abstract][Full Text] [Related]
9. PPAR-γ agonist pioglitazone prevents apoptosis of endothelial progenitor cells from rat bone marrow.
Zhang HF; Wang L; Yuan HJ; Ma YH; Wang YF; Hu ZY; Su Y; Zhao ZG
Cell Biol Int; 2013 May; 37(5):430-5. PubMed ID: 23504801
[TBL] [Abstract][Full Text] [Related]
10. Biphasic effect of pioglitazone on isolated human endothelial progenitor cells: involvement of peroxisome proliferator-activated receptor-gamma and transforming growth factor-beta1.
Redondo S; Hristov M; Gümbel D; Tejerina T; Weber C
Thromb Haemost; 2007 Jun; 97(6):979-87. PubMed ID: 17549301
[TBL] [Abstract][Full Text] [Related]
11. Bcl-2 and Bcl-XL are indispensable for the late phase of mast cell development from mouse embryonic stem cells.
Möller C; Karlberg M; Abrink M; Nakayama KI; Motoyama N; Nilsson G
Exp Hematol; 2007 Mar; 35(3):385-93. PubMed ID: 17309819
[TBL] [Abstract][Full Text] [Related]
12. Involvement of p38 MAP kinase and Smad3 in TGF-beta-mediated mast cell functions.
Funaba M; Ikeda T; Murakami M; Ogawa K; Nishino Y; Tsuchida K; Sugino H; Abe M
Cell Signal; 2006 Dec; 18(12):2154-61. PubMed ID: 16750902
[TBL] [Abstract][Full Text] [Related]
13. Soluble transforming growth factor beta-1 enhances murine mast cell release of Interleukin 6 in IgE-independent and Interleukin 13 in IgE-dependent settings in vitro.
Lyons DO; Plewes MR; Pullen NA
PLoS One; 2018; 13(11):e0207704. PubMed ID: 30444930
[TBL] [Abstract][Full Text] [Related]
14. IgE production in CD40/CD40L cross-talk of B and mast cells and mediator release via TGase 2 in mouse allergic asthma.
Hong GU; Park BS; Park JW; Kim SY; Ro JY
Cell Signal; 2013 Jun; 25(6):1514-25. PubMed ID: 23524335
[TBL] [Abstract][Full Text] [Related]
15. Decreased PPAR-γ expression in the conjunctiva and increased expression of TNF-α and IL-1β in the conjunctiva and tear fluid of dry eye mice.
Chen Y; Zhang X; Yang L; Li M; Li B; Wang W; Sheng M
Mol Med Rep; 2014 May; 9(5):2015-23. PubMed ID: 24626526
[TBL] [Abstract][Full Text] [Related]
16. Stem cell factor and interleukin-4 increase responsiveness of mast cells to substance P.
Karimi K; Redegeld FA; Blom R; Nijkamp FP
Exp Hematol; 2000 Jun; 28(6):626-34. PubMed ID: 10880748
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of adult liver progenitor (oval) cell growth and viability by an agonist of the peroxisome proliferator activated receptor (PPAR) family member gamma, but not alpha or delta.
Knight B; Yeap BB; Yeoh GC; Olynyk JK
Carcinogenesis; 2005 Oct; 26(10):1782-92. PubMed ID: 15917308
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist inhibits transforming growth factor-beta1 and matrix production in human dermal fibroblasts.
Zhang GY; Cheng T; Zheng MH; Yi CG; Pan H; Li ZJ; Chen XL; Yu Q; Jiang LF; Zhou FY; Li XY; Yang JQ; Chu TG; Gao WY
J Plast Reconstr Aesthet Surg; 2010 Jul; 63(7):1209-16. PubMed ID: 19617014
[TBL] [Abstract][Full Text] [Related]
19. PPAR-gamma agonist protects podocytes from injury.
Kanjanabuch T; Ma LJ; Chen J; Pozzi A; Guan Y; Mundel P; Fogo AB
Kidney Int; 2007 Jun; 71(12):1232-9. PubMed ID: 17457378
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of microRNA-29 by antisense inhibitors and a PPAR-gamma agonist protects against myocardial ischaemia-reperfusion injury.
Ye Y; Hu Z; Lin Y; Zhang C; Perez-Polo JR
Cardiovasc Res; 2010 Aug; 87(3):535-44. PubMed ID: 20164119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
